The role of bisoprolol in the management of patients with arterial hypertension
| Autor: | Nedogoda S.V. |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2016 |
| Předmět: | |
| Zdroj: | Системные гипертензии, Vol 13, Iss 3, Pp 32-34 (2016) |
| Druh dokumentu: | article |
| ISSN: | 2075-082X 2542-2189 |
| DOI: | 10.26442/2075-082X_13.3.32-34 |
| Popis: | According to the different recommendations (NICE, JNC-8, ASH/ISH) concerning the treatment of AH, b-blockers are in 3rd–4th place among the other antihypertensive drugs (AHD), because the results of various meta-analyses show that their antihypertensive activity was less potent in comparison with other classes of drugs, their worst impact on hard endpoints (especially in people over 60). The application of beta-blockers can increase the risk of diabetes mellitus (especially in combination of thiazide-type diuretics) and shows negative effects on aortic elasticity. However, "new" b-blockers occupy leading positions because of number of main AHD characteristics (cardioselectivity, amphiphilicity, duration of action, metabolic neutrality, etc.). Bisoprolol can be regarded as the drug of choice in patients with AH associated with ischemic heart disease (stable angina), especially with the trend towards high heart rate, and in patients with chronic heart failure. Bisoprolol is effective both in elderly patients (people over 60) and in younger one (younger than 60). |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|